Clinical Trial Update: Darolutamide + Androgen Deprivation Therapy (ADT) in Chinese Men With High Risk, Nonmetastatic Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating darolutamide in combination with androgen deprivation therapy for high-risk nonmetastatic prostate cancer in Chinese men has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Darolutamide (darolutamide)

Snippet

Sponsor: Bayer | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED